Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute
Eduardo Rodríguez-Arbolí1,2, Megan Othus3, Sylvie D Freeman4
1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Leukemia
|August 21, 2024
Abstract
No abstract available in PubMed .
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
13.9K
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
40
